188Re-NM-02
N/A
Report date: 2025/10/20 14:38:49
NME
Base Information
Drug Name188Re-NM-02
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Jiao Tong University Affiliated First People'S HospitalNanoMab Technology (UK) Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShanghai Jiao Tong University Affiliated First People'S HospitalNanoMab Technology (UK) Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A